Akebia Therapeutics Inc (AKBA) Jumps 6.41% on December 30

Equities Staff |

Akebia Therapeutics Inc (AKBA) was among the biggest gainers on the Russell 2000 for Wednesday December 30 as the stock popped 6.41% to $12.78, representing a gain of $0.77 per share. Some 381,536 shares traded hands on 2,856 trades, compared with an average daily volume of 702,918 shares out of a total float of 30.63 million. The stock opened at $12.06 and traded with an intraday range of $12.85 to $11.92.

After today's gains, Akebia Therapeutics Inc reached a market cap of $391.47 million. Akebia Therapeutics Inc has had a trading range between $14.20 and $5.91 over the last year, and it had a 50-day SMA of $10.14 and a 200-day SMA of $9.40.

Akebia Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.

Akebia Therapeutics Inc is based out of Cambridge, MA and has some 43 employees. Its CEO is John P. Butler.

For a complete fundamental analysis analysis of Akebia Therapeutics Inc , check out Equities.com’s Stock Valuation Analysis report for AKBA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.

Private Markets

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…